In Landmark Court Ruling, Nevada Can’t Use a Controversial Drug to Execute an Inmate

One inmate who wants to die will have to wait.

Sue Ogrocki/AP

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

A judge has made it nearly impossible for the state of Nevada to execute a death row inmate. Clark County District Judge Elizabeth Gonzalez banned prison officials from using its supply of midazolam, a controversial sedative responsible for several botched executions in the past, to execute Scott Dozier—who has given up his appeals and has asked to be executed.

The ruling comes after a monthslong legal battle between Nevada and Alvogen, the company from which the state obtained the drug. Just hours before Dozier was scheduled to be executed in July, the company filed a lawsuit against the state. As Mother Jones reported, Alvogen alleged Nevada had improperly obtained the drug:

The company is alleging that despite a clear warning its product could not be used in executions, Nevada purchased the drugs by “subterfuge.” The suit says the state purchased the drugs through an “unsuspecting intermediary” who would not have sold the product if it had known the drugs were going to be used to put Dozier to death.

Earlier this month, Nevada’s prison director, James Dzurenda, testified that he ignored letters from Alvogen. He messaged Linda Fox, pharmacy director at Ely State Prison, where Dozier is being held, about the letters but did not return the sedatives. “Text messages between Fox and Dzurenda also support Alvogen’s allegation of a scheme,” Gonzalez wrote in her ruling. “The state did not acquire the Alvogen midazolam product in good faith, and it did so knowing that it violated Alvogen’s property rights.” 

The state has not conducted any executions since 2006, when Daryl Mack was put to death by lethal injection. Dozier has been on death row since 2007 for the 2002 murder of Jeremiah Miller. In 2016, against the advice of his lawyer, he opted to skip the remainder of his appeals and asked to be put to death.

It’s unclear how the state will now proceed, but Nevada’s Department of Corrections has said it will only move forward with the execution if it has all three drugs in its protocol.

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate